Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 311

1.

Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).

Flather MD, Shibata MC, Coats AJ, Van Veldhuisen DJ, Parkhomenko A, Borbola J, Cohen-Solal A, Dumitrascu D, Ferrari R, Lechat P, Soler-Soler J, Tavazzi L, Spinarova L, Toman J, Böhm M, Anker SD, Thompson SG, Poole-Wilson PA; SENIORS Investigators.

Eur Heart J. 2005 Feb;26(3):215-25. Epub 2005 Jan 9.

2.

Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure).

van Veldhuisen DJ, Cohen-Solal A, Böhm M, Anker SD, Babalis D, Roughton M, Coats AJ, Poole-Wilson PA, Flather MD; SENIORS Investigators.

J Am Coll Cardiol. 2009 Jun 9;53(23):2150-8. doi: 10.1016/j.jacc.2009.02.046.

3.

[Influence of the beta-blocker nebivolol on left ventricular function in patients with chronic heart failure].

Wolf SC, Buck-Müller N, Görner S, Risler T, Brehm BR.

Med Klin (Munich). 2003 Jan 15;98(1):1-6. German.

PMID:
12540987
4.

Influence of diabetes mellitus and hyperglycemia on prognosis in patients > or =70 years old with heart failure and effects of nebivolol (data from the Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors with heart failure [SENIORS]).

de Boer RA, Doehner W, van der Horst IC, Anker SD, Babalis D, Roughton M, Coats AJ, Flather MD, van Veldhuisen DJ; SENIORS Investigators.

Am J Cardiol. 2010 Jul 1;106(1):78-86.e1. doi: 10.1016/j.amjcard.2010.02.018.

PMID:
20609652
5.

Effects of nebivolol in elderly heart failure patients with or without systolic left ventricular dysfunction: results of the SENIORS echocardiographic substudy.

Ghio S, Magrini G, Serio A, Klersy C, Fucili A, Ronaszèki A, Karpati P, Mordenti G, Capriati A, Poole-Wilson PA, Tavazzi L; SENIORS investigators.

Eur Heart J. 2006 Mar;27(5):562-8. Epub 2006 Jan 27. Erratum in: Eur Heart J. 2006 Jul;27(14):1760. Fucilli, Alessandro [corrected to Fucili, Alessandro].

6.

Tolerability and dose-related effects of nebivolol in elderly patients with heart failure: data from the Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS) trial.

Dobre D, van Veldhuisen DJ, Mordenti G, Vintila M, Haaijer-Ruskamp FM, Coats AJ, Poole-Wilson PA, Flather MD; SENIORS Investigators.

Am Heart J. 2007 Jul;154(1):109-15.

PMID:
17584562
7.

Effects of Nebivolol on left ventricular function and exercise capacity in patients with non-ischaemic dilated cardiomyopathy. A randomised placebo-controlled study.

Patrianakos AP, Parthenakis FI, Mavrakis HE, Saatsaki M, Diakakis GF, Chlouverakis GI, Vardas PE.

Hellenic J Cardiol. 2005 May-Jun;46(3):199-207.

8.

Nebivolol: haemodynamic effects and clinical significance of combined beta-blockade and nitric oxide release.

Kamp O, Metra M, Bugatti S, Bettari L, Dei Cas A, Petrini N, Dei Cas L.

Drugs. 2010;70(1):41-56. doi: 10.2165/11530710-000000000-00000.

PMID:
20030424
9.
10.

Efficacy and safety of nebivolol in elderly heart failure patients with impaired renal function: insights from the SENIORS trial.

Cohen-Solal A, Kotecha D, van Veldhuisen DJ, Babalis D, Böhm M, Coats AJ, Roughton M, Poole-Wilson P, Tavazzi L, Flather M; SENIORS Investigators.

Eur J Heart Fail. 2009 Sep;11(9):872-80. doi: 10.1093/eurjhf/hfp104. Epub 2009 Aug 1.

11.

Anaemia among patients with heart failure and preserved or reduced ejection fraction: results from the SENIORS study.

von Haehling S, van Veldhuisen DJ, Roughton M, Babalis D, de Boer RA, Coats AJ, Manzano L, Flather M, Anker SD.

Eur J Heart Fail. 2011 Jun;13(6):656-63. doi: 10.1093/eurjhf/hfr044.

12.

Effect of nebivolol on outcome in elderly patients with heart failure and atrial fibrillation: insights from SENIORS.

Mulder BA, van Veldhuisen DJ, Crijns HJ, Böhm M, Cohen-Solal A, Babalis D, Roughton M, Flather MD, Coats AJ, Van Gelder IC.

Eur J Heart Fail. 2012 Oct;14(10):1171-8. Epub 2012 Jul 4.

13.

Nebivolol for heart failure in the elderly.

Tavazzi L.

Expert Rev Cardiovasc Ther. 2007 May;5(3):423-33. Review.

PMID:
17489667
14.

Nebivolol in the treatment of cardiac failure: a double-blind controlled clinical trial.

Uhlir O, Dvorak I, Gregor P, Malek I, Spinarova L, Vojacek J, Van Nueten L.

J Card Fail. 1997 Dec;3(4):271-6.

PMID:
9547441
15.

Long-term (3-month) effects of a new beta-blocker (nebivolol) on cardiac performance in dilated cardiomyopathy.

Wisenbaugh T, Katz I, Davis J, Essop R, Skoularigis J, Middlemost S, Röthlisberger C, Skudicky D, Sareli P.

J Am Coll Cardiol. 1993 Apr;21(5):1094-100.

16.

The role of the new beta-blockers in treating cardiovascular disease.

Weber MA.

Am J Hypertens. 2005 Dec;18(12 Pt 2):169S-176S. Review.

PMID:
16373195
17.

Long-term cost-effectiveness analysis of nebivolol compared with standard care in elderly patients with heart failure: an individual patient-based simulation model.

Yao G, Freemantle N, Flather M, Tharmanathan P, Coats A, Poole-Wilson PA; SENIORS Investigators.

Pharmacoeconomics. 2008;26(10):879-89.

PMID:
18793034
18.

Nebivolol: a third-generation beta-blocker for hypertension.

Cheng JW.

Clin Ther. 2009 Mar;31(3):447-62. doi: 10.1016/j.clinthera.2009.03.007. Review.

PMID:
19393838
19.

Nebivolol for the treatment of heart failure.

Dery AS, Hamilton LA, Starr JA.

Am J Health Syst Pharm. 2011 May 15;68(10):879-86. doi: 10.2146/ajhp100309.

PMID:
21546638
20.

[Role of the L-arginine/nitric oxide system in the action of nebivolol].

Brodde OE, Philipp T.

Dtsch Med Wochenschr. 2006 Nov 10;131(45):2545-50. Review. German.

PMID:
17091442
Items per page

Supplemental Content

Write to the Help Desk